CClinicalTrials.gg
RecruitingNCT06828575Updated Mar 4, 2025

Evaluation of the Success of Artificial Intelligence Models in Interpreting Arterial Waveform Analysis Data

An observational study in Hemodynamic Instability, sponsored by Kanuni Sultan Suleyman Training and Research Hospital. Recruiting at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-04.

Sponsored by Kanuni Sultan Suleyman Training and Research Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 1 month ago, but the record still lists the study as recruiting.
  • Started Feb 2025; still recruiting 1 year 7 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
145
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to evaluate the ability of artificial intelligence (AI) models to interpret arterial waveform analysis data obtained from a hemodynamic monitoring system in adult patients undergoing elective surgery. The main questions it aims to answer are:

Can AI models (ChatGPT-4 and Gemini 2.0) accurately detect hemodynamic abnormalities in arterial waveform data? How well do AI-generated diagnoses align with expert anesthesiologist assessments? Are AI-generated treatment recommendations clinically appropriate?

Participants will:

Undergo standard hemodynamic monitoring with an arterial waveform analysis device (MostCare).

Have their anonymized hemodynamic data analyzed by AI models for abnormality detection, diagnosis suggestions, and treatment recommendations.

Have AI-generated results reviewed and validated by experienced anesthesiologists.

This study aims to assess whether AI models can serve as decision-support tools in perioperative and critical care settings by improving the interpretation of complex hemodynamic data, potentially enhancing patient safety, diagnostic accuracy, and clinical efficiency.

Read the detailed description

This prospective observational study aims to evaluate the ability of artificial intelligence (AI) models to interpret arterial waveform analysis data obtained from a hemodynamic monitoring system. The study will focus on assessing the accuracy of ChatGPT-4 and Gemini 2.0 in detecting hemodynamic abnormalities, providing diagnostic suggestions, and offering treatment recommendations based on arterial waveform data collected from elective surgical patients.

Background and Rationale Arterial waveform analysis is a critical component of advanced hemodynamic monitoring, providing real-time insights into cardiac output, vascular resistance, and volume status. These parameters are essential for guiding perioperative fluid management and optimizing hemodynamic stability in surgical and critically ill patients. While automated monitoring systems generate large amounts of data, the interpretation of these waveforms remains dependent on clinician expertise. The integration of AI-based decision-support tools in this context could enhance real-time clinical decision-making and reduce workload for healthcare providers.

Study Objectives

The primary objective of this study is to determine the ability of AI models to analyze arterial waveform data and detect clinically significant hemodynamic abnormalities. The secondary objectives are:

To assess the concordance between AI-generated diagnoses and expert anesthesiologist assessments.

To evaluate the clinical appropriateness of AI-generated treatment recommendations.

To explore the potential role of AI in clinical decision support systems for hemodynamic monitoring.

Study Design and Methodology

This study will be conducted at two tertiary-level healthcare institutions:

Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital Başakşehir Çam and Sakura City Hospital The study will include adult patients undergoing elective surgery who require intraoperative arterial waveform monitoring as part of routine perioperative care.

Data Collection Process Hemodynamic data will be collected from participants using the MostCare hemodynamic monitoring system, which is routinely used in perioperative settings.

Data collection will take place at three time points:

Pre-anesthesia (baseline hemodynamic status before induction) Post-anesthesia induction (after intubation, before surgical incision) Intraoperative period (during key surgical events requiring hemodynamic intervention) If an intervention needs according to arterial wave analysis we will also take data before and after intervention.

AI-Based Analysis

The collected arterial waveform data will be anonymized and processed by AI models (ChatGPT-4 and Gemini 2.0) to provide:

Abnormality detection - Identifying any deviations from normal hemodynamic parameters.

Diagnostic suggestions - Providing likely clinical diagnoses based on the waveform patterns.

Treatment recommendations - Suggesting possible interventions to optimize hemodynamic status.

Expert Validation AI-generated results will be independently reviewed by experienced anesthesiologists to assess their accuracy and clinical relevance.

The concordance between AI outputs and expert assessments will be statistically analyzed.

Outcome Measures

Primary Outcome:

Accuracy of AI models in detecting hemodynamic abnormalities compared to expert assessments.

Secondary Outcomes:

Concordance between AI-generated diagnoses and anesthesiologist diagnoses. Clinical appropriateness of AI-generated treatment recommendations compared to standard clinical practice.

AI models' potential role in enhancing clinical decision-making in perioperative hemodynamic management.

Ethical Considerations The study does not involve any additional interventions beyond routine clinical monitoring.

No patient-identifiable data will be used in AI model analysis. Informed consent will be obtained from all participants before enrollment. The study has been approved by the relevant ethics committees at both participating institutions.

Study Timeline Planned study duration: 6 months Estimated start date: February 15, 2025 Estimated completion date: August 15, 2025 Potential Impact

This study will provide valuable insights into the role of AI in automated hemodynamic monitoring and perioperative decision support. If successful, AI-driven analysis of arterial waveform data could:

Enhance patient safety through early detection of hemodynamic abnormalities. Improve efficiency by assisting anesthesiologists in data interpretation. Reduce workload for perioperative and critical care teams. Support future AI-based clinical decision-support tools for hemodynamic monitoring.

02

Conditions studied

  • Hemodynamic Instability
03

In context

Lead sponsor

Kanuni Sultan Suleyman Training and Research Hospital is the lead sponsor of 216 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

This study will include adult patients (≥18 years old) undergoing elective surgery requiring intraoperative arterial waveform monitoring as part of routine perioperative care. The population will consist of patients from two tertiary-level hospitals where advanced hemodynamic monitoring with the MostCare system is regularly utilized.

Participants will be selected based on their eligibility for continuous arterial pressure monitoring, ensuring a standardized dataset for AI analysis. The study population will represent a diverse range of surgical procedures, including but not limited to:

General surgery (e.g., abdominal, hepatobiliary, colorectal procedures)

Inclusion criteria

  • Age ≥ 18 years
  • Undergoing elective surgery with arterial waveform monitoring as part of standard perioperative care
  • Hemodynamic data successfully recorded using the MostCare hemodynamic monitoring system
  • Able to provide informed consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Incomplete or corrupted hemodynamic data (e.g., signal artifacts preventing reliable analysis)
  • Emergency surgery cases
  • Patients with severe arrhythmias or hemodynamic instability that might interfere with arterial waveform interpretation
  • Refusal to participate or withdrawal of consent
  • Patients with contraindications to arterial catheterization (e.g., coagulopathy, severe peripheral vascular disease)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
145 participants (estimated)
Patient registry
No

Interventions

  • Otherpredictions

    predictions of learning language models

06

What researchers measure

Primary outcomes

  1. Accuracy

    Accuracy of AI models in detecting hemodynamic abnormalities (True or False).

    Time frame: 1 day

Secondary outcomes

  1. Concordance Between AI-Generated Diagnoses and Expert Anesthesiologist Diagnoses

    AI-generated diagnostic suggestions will be compared with the final diagnosis made by anesthesiologists (True or False).

    Time frame: 1 DAY

  2. Clinical Appropriateness of AI-Generated Treatment Recommendations

    The relevance and accuracy of AI-suggested treatments will be evaluated against standard clinical management (True or False).

    Time frame: 1 DAY

07

Study locations

1 of 1 sites recruiting
  • Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital
    Istanbul, 34303, Turkey
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06828575
Lead sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Responsible party
Engin Ihsan Turan (anesthesiology and reanimation specialist, Kanuni Sultan Suleyman Training and Research Hospital) — Principal investigator
First posted
Feb 14, 2025
Start date
Feb 15, 2025
Primary completion
Aug 15, 2025 (estimated)
Completion
Aug 16, 2025 (estimated)
Last update
Mar 4, 2025

Study contacts

Engin ihsan Turan, Specialist
Contact
enginihsan@hotmail.com
05382431114

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion